Analyst Research Report Snapshot

Title:

Takeda Pharmaceutical Company Limited

Price:

$175.00

Provider:

MarketLine (a Datamonitor Company)

Date:

08 Apr 2014

Pages:

60

Type:

AcrobatPDF

Companies referenced:

4502.T

Available for Immediate Download
Summary:

Takeda Pharmaceutical Company Limited - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Takeda Pharmaceutical Company Limited required for business and competitor intelligence needs - A study of the major internal and external factors affecting Takeda Pharmaceutical Company Limited in the form of a SWOT analysis - An in-depth view of the business model of Takeda Pharmaceutical Company Limited including a breakdown and examination of key business segments - Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Takeda Pharmaceutical Company Limited - Intelligence on Takeda Pharmaceutical Company Limitednv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Takeda Pharmaceutical Company Limited, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Takeda Pharmaceutical Company Limited (Takeda or 'the company') is a research-based global company with its main focus on pharmaceuticals. The company markets its products in about 100 countries. It is headquartered in Osaka, Japan and employed 30,305 people as of March 31, 2012. The company recorded revenues of JPY1,508,932 million ($19,163.4 million*) during the financial year ended March 2012 (FY2012), an increase of 6.3% over FY2011. The operating profit of the company was JPY265,027 million ($3,365.8 million*) in FY2012, a decrease of 27.8% compared with FY2011. The net profit was JPY124,162 million ($1,576.9 million*) in FY2012, a decrease of 49.9% compared with FY2011. *Calculated using a constant conversion rate of JPY1 = $ 0.0127 for the year ended March 31, 2012. Reasons to Purchase: - Gain understanding of Takeda Pharmaceutical Company Limited and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Takeda Pharmaceutical Company Limited as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Takeda Pharmaceutical Company Limited’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.